TFMP (Tropomyosin-derived peptide) is a class of small peptide inhibitors utilized in oncology research to target and block vascular endothelial growth factor receptors, thereby inhibiting tumor angiogenesis.… Read more










TFMP (Tropomyosin-derived peptide) is a class of small peptide inhibitors utilized in oncology research to target and block vascular endothelial growth factor receptors, thereby inhibiting tumor angiogenesis. This category includes a specialized selection of related analytical standards, such as DOTA-TFMP and FAPI-based variants, which are essential for rigorous scientific investigation. These high-quality reference materials allow researchers to perform accurate impurity profiling, pharmacokinetic studies, and precise method validation for TFMP-based radiopharmaceuticals. By utilizing these stable isotope labelled compounds and related peptide standards, pharmaceutical laboratories can ensure the consistency and reliability of their quality control processes during the development of these therapeutic agents. These analytical tools are vital for characterizing complex peptide structures and supporting regulatory compliance in the analysis of novel anti-angiogenic candidates.